Diagnostic value of fine needle aspiration BRAFV600E mutation analysis in papillary thyroid cancer: A systematic review and meta-analysis

Human Pathology

Volumn 46, Issue 10, 2015, Pages 1443-1454

  Fnais, Naif ^a   Soobiah, Charlene ^b   Al Qahtani, Khalid ^a   Hamid, Jemila S ^b,c   Perrier, Laure ^b   Straus, Sharon E ^b,d   Tricco, Andrea C ^b,e  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

^b ST MICHAEL'S HOSPITAL   (Canada)

^c MCMASTER UNIVERSITY   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

^e UNIVERSITY OF TORONTO   (Canada)

Author keywords

BRAFV600E mutation; Meta analysis; Papillary thyroid cancer; Sensitivity; Specificity; Systematic review

Indexed keywords

BRAF V600E GENE; CANCER PATIENT; CANCER SCREENING; CONFERENCE PAPER; CYTODIAGNOSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; FINE NEEDLE ASPIRATION BIOPSY; GENE MUTATION; GENE REARRANGEMENT; HUMAN; META ANALYSIS; MULTICENTER STUDY (TOPIC); ONCOGENE; OUTCOME ASSESSMENT; SENSITIVITY AND SPECIFICITY; SYSTEMATIC REVIEW; THYROID NODULE; THYROID PAPILLARY CARCINOMA; AREA UNDER THE CURVE; CARCINOMA; GENETICS; NUCLEOTIDE SEQUENCE; PROCEDURES; RECEIVER OPERATING CHARACTERISTIC; THYROID NEOPLASMS;

B RAF KINASE; BRAF PROTEIN, HUMAN;

AREA UNDER CURVE; BIOPSY, FINE-NEEDLE; CARCINOMA; DNA MUTATIONAL ANALYSIS; HUMANS; PROTO-ONCOGENE PROTEINS B-RAF; ROC CURVE; SENSITIVITY AND SPECIFICITY; THYROID NEOPLASMS;

EID: 84941936292     PISSN: 00468177     EISSN: 15328392     Source Type: Journal    
DOI: 10.1016/j.humpath.2015.06.001     Document Type: Conference Paper

References (77)

1. S.A. Hundahl, I.D. Fleming, A.M. Fremgen, and H.R. Menck A National Cancer Data Base report on 53,856 cases of thyroid carcinoma treated in the U.S., 1985-1995 Cancer 83 1998 2638 2648
2. I.C. Paterson, R. Greenlee, and J.D. Adams Thyroid cancer in Wales 1985-1996: a cancer registry-based study Clin Oncol 11 1999 245 251
3. N. Howlader, A.M. Noone, M. Krapcho, and et al. SEER Cancer Statistics Review, 1975-2009 (Vintage 2009 Populations) 2012 National Cancer Institute Bethesda, MD [ http://seer.cancer.gov/csr/1975-2009-pops09/. Accessed Sep 30, 2013]
4. C. Nucera, J. Lawler, R. Hodin, and S. Parangi The BRAFV600E mutation: what is it really orchestrating in thyroid cancer? Oncotarget 1 2010 751 756
5. M. Xing, R.P. Tufano, A.P. Tufaro, and et al. Detection of BRAF mutation on fine needle aspiration biopsy specimens: a new diagnostic tool for papillary thyroid cancer J Clin Endocrinol Metab 89 2004 2867 2872
6. S.W. Kim, J.I. Lee, J.W. Kim, and et al. BRAFV600E mutation analysis in fine-needle aspiration cytology specimens for evaluation of thyroid nodule: a large series in a BRAF V600E-prevalent population J Clin Endocrinol Metab 95 2010 3693 3700
7. H. Namba, M. Nakashima, T. Hayashi, and et al. Clinical implication of hot spot BRAF mutation, V599E, in papillary thyroid cancers J Clin Endocrinol Metab 88 2003 4393 4397
8. M. Xing BRAF mutation in thyroid cancer Endocr Relat Cancer 12 2005 245 262
9. C. Peyssonnaux, and A. Eychene The Raf/MEK/ERK pathway: new concepts of activation Biol Cell 93 2001 53 62
10. R.A. Hilger, M.E. Scheulen, and D. Strumberg The Ras-Raf-MEK-ERK pathway in the treatment of cancer Onkologie 25 2002 511 518
11. B.G. Bentz, B.T. Miller, J.A. Holden, and et al. B-RAF V600E mutational analysis of fine needle aspirates correlates with diagnosis of thyroid nodules Otolaryngol Head Neck Surg 140 5 2009 709 714
12. A. Jemal, R. Siegel, J. Xu, and E. Ward Cancer Statistics, 2010 CA Cancer J Clin 60 2010 277 300
13. H. Nakayama, A. Yoshida, Y. Nakamura, and et al. Clinical significance of BRAF (V600E) mutation and Ki-67 labeling index in papillary thyroid carcinomas Anticancer Res 27 2007 3645 3650
14. M.N. Nikiforova, E.T. Kimura, M. Gandhi, and et al. BRAF mutations in thyroid tumors are restricted to papillary carcinomas and anaplastic or poorly differentiated carcinomas arising from papillary carcinomas J Clin Endocrinol Metab 88 11 2003 5399 5404
15. G. Riesco-Eizaguirre, P. Gutiérrez-Martínez, M.A. García-Cabezas, M. Nistal, and P. Santisteban The oncogene BRAF V600E is associated with a high risk of recurrence and less differentiated papillary thyroid carcinoma due to the impairment of Na+/I- targeting to the membrane Endocr Relat Cancer 13 2006 257 269
16. American Thyroid Association (ATA) Guidelines Taskforce on Thyroid Nodules and Differentiated Thyroid Cancer, D.S. Cooper, G.M. Doherty, and et al. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer Thyroid 19 2009 1167 1214
17. F. Pacini, M. Schlumberger, H. Dralle, and et al. European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium Eur J Endocrinol 154 2006 787 803
18. C.S. Cibas, S.Z. Ali NCI Thyroid FNA State of the Science Conference The Bethesda System for Reporting Thyroid Cytopathology Am J Clin Pathol 132 2009 658 665
19. K.W. Chung, S.K. Yang, G.K. Lee, and et al. Detection of BRAFV600E mutation on fine needle aspiration specimens of thyroid nodule refines cyto-pathology diagnosis, especially in BRAF600E mutation-prevalent area Clin Endocrinol (Oxf) 65 2006 660 666
20. Y. Cohen, E. Rosenbaum, D.P. Clark, and et al. Mutational analysis of BRAF in fine needle aspiration biopsies of the thyroid: a potential application for the preoperative assessment of thyroid nodules Clin Cancer Res 10 2004 2761 2765
21. H.Y. Chang, H. Lee, S.O. Yoon, and et al. BRAFV600E mutation analysis of liquid-based preparation-processed fine needle aspiration sample improves the diagnostic rate of papillary thyroid carcinoma Hum Pathol 43 2012 89 95
22. L. Shamseer, D. Moher, M. Clarke, and et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation BMJ 349 2015 g7647
23. J.B. Reitsma, A.W.S. Rutjes, P. Whiting, V.V. Vlassov, M.M.G. Leeflang, and J.J. Deeks Chapter 9: assessing methodological quality J.J. Deeks, P.M. Bossuyt, C. Gatsonis, Cochrane Handbook for Systematic Reviews of Diagnostic Test Accuracy Version 1.0.0. The Cochrane Collaboration 2009
24. L. Arends, T. Hamza, J. Van Houwelingen, M. Heijenbrok-Kal, M. Hunink, and T. Stijnen Bivariate random effects meta-analysis of ROC curves Med Decis Making 28 2008 621 638
25. J. Reitsma, A. Glas, A. Rutjes, R. Scholten, P. Bossuyt, and A. Zwinderman Bivariate analysis of sensitivity and specificity produces informative summary measures in diagnostic reviews J Clin Epidemiol 58 2005 982 990
26. R. Development Core Team R: a language and environment for statistical computing R Foundation for Statistical Computing, Vienna, Austria 2011 3-900051-07-0 [URL http://www.R-project.org/]
27. N. Hayashida, H. Namba, A. Kumagai, and et al. A rapid and simple detection method for the BRAF(T1796A) mutation in fine-needle aspirated thyroid carcinoma cells Thyroid 14 2004 910 915
28. G. Salvatore, R. Giannini, P. Faviana, and et al. Analysis of BRAF point mutation and RET/PTC rearrangement refines the fine-needle aspiration diagnosis of papillary thyroid carcinoma J Clin Endocrinol Metab 89 2004 5175 5180
29. R. Domingues, E. Mendonca, L. Sobrinho, and et al. Searching for RET/PTC rearrangements and BRAF V599E mutation in thyroid aspirates might contribute to establish a preoperative diagnosis of papillary thyroid carcinoma Cytopathology 16 2005 27 31
30. L. Jin, T.J. Sebo, N. Nakamura, and et al. BRAF mutation analysis in fine needle aspiration (FNA) cytology of the thyroid Diagn Mol Pathol 15 2006 136 143
31. L.R. Rowe, B.G. Bentz, and J.S. Bentz Detection of BRAF V600E activating mutation in papillary thyroid carcinoma using PCR with allele-specific fluorescent probe melting curve analysis J Clin Pathol 60 2007 1211 1215
32. G. Pizzolanti, L. Russo, P. Richiusa, and et al. Fine-needle aspiration molecular analysis for the diagnosis of papillary thyroid carcinoma through BRAF V600E mutation and RET/PTC rearrangement Thyroid 17 2007 1109 1115
33. M.R. Sapio, A. Guerra, D. Posca, and et al. Combined analysis of galectin-3 and BRAFV600E improves the accuracy of fine-needle aspiration biopsy with cytological findings suspicious for papillary thyroid carcinoma Endocr Relat Cancer 14 2007 1089 1097
34. M.R. Sapio, D. Posca, A. Raggioli, and et al. Detection of RET/PTC, TRK and BRAF mutations in preoperative diagnosis of thyroid nodules with indeterminate cytological findings Clin Endocrinol (Oxf) 66 2007 678 683
35. S.K. Kim, D.L. Kim, H.S. Han, and et al. Pyrosequencing analysis for detection of a BRAFV600E mutation in an FNAB specimen of thyroid nodules Diagn Mol Pathol 17 2008 118 125
36. Y.S. Jo, S. Huang, Y.J. Kim, and et al. Diagnostic value of pyrosequencing for the BRAF V600E mutation in ultrasound-guided fine-needle aspiration biopsy samples of thyroid incidentalomas Clin Endocrinol (Oxf) 70 2009 139 144
37. S.K. Kim, K.H. Song, S.D. Lim, and et al. Clinical and pathological features and the BRAFV600E mutation in patients with papillary thyroid carcinoma with and without concurrent hashimoto thyroiditis Thyroid 19 2009 137 141
38. J.Y. Kwak, E.K. Kim, W.Y. Chung, and et al. Association of BRAFV600E mutation with poor clinical prognostic factors and US features in Korean patients with papillary thyroid microcarcinoma Radiology 253 2009 854 860
39. I. Marchetti, F. Lessi, C.M. Mazzanti, and et al. A morpho-molecular diagnosis of papillary thyroid carcinoma: BRAF V600E detection as an important tool in preoperative evaluation of fine-needle aspirates Thyroid 19 2009 837 842
40. H.J. Moon, J.Y. Kwak, E.K. Kim, and et al. The role of BRAFV600E mutation and ultrasonography for the surgical management of a thyroid nodule suspicious for papillary thyroid carcinoma on cytology Ann Surg Oncol 16 2009 3125 3131
41. M. Xing, D. Clark, H. Guan, and et al. BRAF mutation testing of thyroid fine-needle aspiration biopsy specimens for preoperative risk stratification in papillary thyroid cancer J Clin Oncol 27 18 2009 2977 2982
42. M.C. Zatelli, G. Trasforini, S. Leoni, and et al. BRAF V600E mutation analysis increases diagnostic accuracy for papillary thyroid carcinoma in fine-needle aspiration biopsies Eur J Endocrinol 161 2009 467 473
43. L. Yip, M.N. Nikiforova, S.E. Carty, and et al. Optimizing surgical treatment of papillary thyroid carcinoma associated with BRAF mutation Surgery 146 2009 1215 1223
44. Y.E. Nikiforov, D.L. Steward, T.M. Robinson-Smith, and et al. Molecular testing for mutations in improving the fine-needle aspiration diagnosis of thyroid nodules J Clin Endocrinol Metab 94 2009 2092 2098
45. S. Cantara, M. Capezzone, S. Marchisotta, and et al. Impact of proto-oncogene mutation detection in cytological specimens from thyroid nodules improves the diagnostic accuracy of cytology J Clin Endocrinol Metab 95 2010 1365 1369
46. S. Girlando, L.V. Cuorvo, M. Bonzanini, and et al. High prevalence of B-RAF mutation in papillary carcinoma of the thyroid in north-east Italy Int J Surg Pathol 18 2010 173 176
47. F. Guo, P. Hou, and B. Shi Detection of BRAF mutation on fine needle aspiration biopsy specimens: diagnostic and clinical implications for papillary thyroid cancer Acta Cytol 54 2010 291 295
48. J. Hwang, J.H. Shin, B.-. Han, and et al. Papillary thyroid carcinoma with BRAFV600E mutation: sonographic prediction Am J Roentgenol 194 2010 W425 W430
49. J.Y. Kwak, E.K. Kim, J.K. Kim, and et al. Dual priming oligonucleotide-based multiplex PCR analysis for detection of BRAFV600E mutation in FNAB samples of thyroid nodules in BRAF V600E mutation-prevalent area Head Neck 32 2010 490 498
50. S.J. Lee, M.H. Lee, D.W. Kim, and et al. Cross-regulation between oncogenic BRAF(V600E) kinase and the MST1 pathway in papillary thyroid carcinoma PLoS One 6 1 2011 e16180
51. K.L. Lin, O.C. Wang, X.H. Zhang, X.X. Dai, X.Q. Hu, and J.M. Qu The BRAF mutation is predictive of aggressive clinicopathological characteristics in papillary thyroid microcarcinoma Ann Surg Oncol 17 2010 3294 3300
52. T.J. Musholt, C. Fottner, M.M. Weber, and et al. Detection of papillary thyroid carcinoma by analysis of BRAF and RET/PTC1 mutations in fine-needle aspiration biopsies of thyroid nodules World J Surg 34 2010 2595 2603
53. N.P. Ohori, M.N. Nikiforova, K.E. Schoedel, and et al. Contribution of molecular testing to thyroid fine-needle aspiration cytology of "follicular lesion of undetermined significance/atypia of undetermined significance" Cancer Cytopathol 118 2010 17 23
54. A. Proietti, R. Giannini, C. Ugolini, and et al. BRAF status of follicular variant of papillary thyroid carcinoma and its relationship to its clinical and cytological features Thyroid 20 2010 1263 1270
55. A.J. Adeniran, P. Hui, D.C. Chhieng, and et al. BRAF mutation in thyroid FNA specimens enhances predictability of malignancy in thyroid follicular lesion of undetermined significance Acta Cytol 55 2011 570 575
56. A.J. Adeniran, C. Theoharis, P. Hui, and et al. Reflex BRAF testing in thyroid fine-needle aspiration biopsy with equivocal and positive interpretation: a prospective study Thyroid 21 2011 717 723
57. A. Colanta, M. Arcila, L. Tafe, and et al. BRAF mutation analysis of fine-needle aspiration biopsies of papillary thyroid carcinoma: impact on diagnosis and prognosis Acta Cytol 55 2011 563 569
58. S.K. Kim, T.S. Hwang, Y.B. Yoo, and et al. Surgical results of thyroid nodules according to a management guideline based on the BRAFV600E mutation status J Clin Endocrinol Metab 96 2011 658 664
59. H.J. Moon, E.K. Kim, W.Y. Chung, and et al. Diagnostic value of BRAF(V600E) mutation analysis of thyroid nodules according to ultrasonographic features and the time of aspiration Ann Surg Oncol 18 2011 792 799
60. M.R. Pelizzo, I.M. Boschin, S. Barollo, and et al. BRAF analysis by fine needle aspiration biopsy of thyroid nodules improves preoperative identification of papillary thyroid carcinoma and represents a prognostic factor. A mono-institutional experience Clin Chem Lab Med 49 2011 325 329
61. G. Kang, E.Y. Cho, J.H. Shin, J.H. Chung, J.W. Kim, and Y.L. Oh Role of BRAFV600E mutation analysis and second cytologic review of fine-needle aspiration for evaluating thyroid nodule Cancer Cytopathol 120 2012 44 51
62. W.J. Moon, N. Choi, J.W. Choi, S.K. Kim, and T.S. Hwang BRAF mutation analysis and sonography as adjuncts to fine-needle aspiration cytology of papillary thyroid carcinoma: their relationships and roles Am J Roentgenol 198 2012 668 674
63. M. Rossi, M. Buratto, S. Bruni, and et al. Role of ultrasonographic/clinical profile, cytology, and BRAF V600E mutation evaluation in thyroid nodule screening for malignancy: a prospective study J Clin Endocrinol Metab 97 2012 2354 2361
64. N.P. Ohori, R. Singhal, M.N. Nikiforova, and et al. BRAF mutation detection in indeterminate thyroid cytology specimens: underlying cytologic, molecular, and pathologic characteristics of papillary thyroid carcinoma Cancer Cytopathol 121 2013 197 205
65. E.D. Rossi, M. Martini, S. Capodimonti, and et al. BRAF (V600E) mutation analysis on liquid-based cytology-processed aspiration biopsies predicts bilaterality and lymph node involvement in papillary thyroid microcarcinoma Cancer Cytopathol 121 2013 291 297
66. P. Aragon Han, M.T. Olson, R. Fazeli, and et al. The impact of molecular testing on the surgical management of patients with thyroid nodules Ann Surg Oncol 21 2014 1862 1869
67. J. Hyeon, S. Ahn, J.H. Shin, and Y.L. Oh The prediction of malignant risk in the category "atypia of undetermined significance/follicular lesion of undetermined significance" of the Bethesda System for Reporting Thyroid Cytopathology using subcategorization and BRAF mutation results Cancer Cytopathol 122 2014 368 376
68. D.N. Poller, S. Glaysher, A. Agrawal, S. Caldera, D. Kim, and C. Yiangou BRAF V600 co-testing in thyroid FNA cytology: short-term experience in a large cancer centre in the UK J Clin Pathol 67 2014 684 689
69. Y. Jia, Y. Yu, X. Li, and et al. Diagnostic value of B-RAF(V600E) in difficult-to-diagnose thyroid nodules using fine-needle aspiration: systematic review and meta-analysis Diagn Cytopathol 42 2014 94 101
70. J.H. Lee, E.S. Lee, and Y.S. Kim Clinicopathologic significance of BRAF V600E mutation in papillary carcinomas of the thyroid: a meta-analysis Cancer 110 2007 38 46
71. M. Xing, A.S. Alzahrani, K.A. Carson, and et al. Association between BRAF V600E mutation and mortality in patients with papillary thyroid cancer JAMA 309 2013 1493 1501
72. G.M. Howell, M.N. Nikiforova, S.E. Carty, and et al. BRAF V600E mutation independently predicts central compartment lymph node metastasis in patients with papillary thyroid cancer Ann Surg Oncol 20 2013 47 52
73. J.Y. Joo, J.Y. Park, Y.H. Yoon, and et al. Prediction of occult central lymph node metastasis in papillary thyroid carcinoma by preoperative BRAF analysis using fine-needle aspiration biopsy: a prospective study J Clin Endocrinol Metab 97 2012 3996 4003
74. M. Xing BRAF mutation in papillary thyroid cancer: pathogenic role, molecular bases, and clinical implications Endocr Rev 28 7 2007 742 762
75. D. Chudova, J.I. Wilde, E.T. Wang, and et al. Molecular classification of thyroid nodules using high-dimensionality genomic data J Clin Endocrinol Metab 95 2010 5296 5304
76. L.J. DeGroot, E.L. Kaplan, M. McCormick, and F.H. Straus Natural history, treatment, and course of papillary thyroid carcinoma J Clin Endocrinol Metab 71 1990 414 424
77. J.G. Lijmer, B.W. Mol, S. Heisterkamp, and et al. Empirical evidence of design-related bias in studies of diagnostic tests JAMA 282 1999 1061 1066